Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulationGrowth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunitiesActivation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.The therapeutic role of niacin in dyslipidemia managementLipoprotein lipase, a key role in atherosclerosis?Role of insulin and free fatty acids in the regulation of ob gene expression and plasma leptin in normal rats.PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males.Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study.PPARα gene polymorphisms modulate the association between physical activity and cardiometabolic risk.Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain InjuryBetulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.Fetal origins of adult disease: epidemiology and mechanisms.Peripheral vascular disease and type 2 diabetes mellitus.Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.Mutation analysis of the retinoid X receptor beta, nuclear-related receptor 1, and peroxisome proliferator-activated receptor alpha genes in schizophrenia and alcohol dependence: possible haplotype association of nuclear-related receptor 1 gene to aPerspectives on vascular biology and diabetes.The significance of genetic polymorphisms in modulating the response to lipid-lowering drugs.FADS1 FADS2 gene cluster, PUFA intake and blood lipids in children: results from the GINIplus and LISAplus studiesTherapeutic considerations for postprandial dyslipidaemia.Common problems in the management of hypertriglyceridemia.The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker.Smoking diminishes the beneficial effect of statins: observations from the landmark trials.Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.Mixed modeling of meta-analysis P-values (MixMAP) suggests multiple novel gene loci for low density lipoprotein cholesterol.Lipoprotein lipase: from gene to obesity.Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissueAdiponectin, a key adipokine in obesity related liver diseasesLipid lowering agents are associated with a slower cognitive decline in Alzheimer's diseasePharmacotherapy for dyslipidaemia--current therapies and future agents.Lipids and atherosclerosis.HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular disease.A phase II clinical trial to investigate the effect of pioglitazone on (18)F-FDG uptake in malignant lesions.The effect of experimental osteoporosis on bone regeneration: part 2, proteomics results.Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed miceDrug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.FIELD study.Sports genetics: the PPARA gene and athletes' high ability in endurance sports. A systematic review and meta-analysisInteraction between a common variant in FADS1 and erythrocyte polyunsaturated fatty acids on lipid profile in Chinese Hans.
P2860
Q21245560-28C498DC-444F-4245-852D-27CBF4B95F62Q24291501-6F145956-1915-46AC-8215-750B01ABB7DEQ24553125-F8534294-7BD0-4EBB-94C1-AF6386172A6CQ24793111-F3121908-D48F-4B69-B212-1579692827B0Q24806958-368C4E42-18CB-4EC4-AE21-BE968D521A87Q28304559-25DA32BA-6D3E-4AFC-91B2-0C10D39A2718Q30820478-066D6432-6D8A-41AC-9CAA-45980ADC052BQ33211418-E7649516-2D2A-4555-A85F-EBE044E98466Q33294503-901FA1D7-5003-4E66-9BCB-4DD2479E0403Q33400334-88C4375F-7521-41FE-A697-9FA9B8771C75Q33728875-801A5B5B-631F-453E-A9E7-84940BFD5E9DQ33729415-7E141059-8D55-4486-937E-36B866182CC7Q33916179-9E2D9DC6-468C-442C-96D3-9B676C17E90EQ33928973-8113074D-4610-4972-B3AA-A29903752ECCQ34071984-57EDF49B-2C75-43E8-BCBE-B242E949D631Q34099115-D3675EFF-86B4-4F7E-9247-A57661976EBEQ34113735-4C9BD90A-39EB-4E9C-8DAB-17983014B45DQ34161037-9BE99508-2478-4E85-94D3-68F694E85736Q34258208-2B475A7B-E409-48AD-B13E-356E713B0D4DQ34282136-A9B42823-7388-4BD0-9717-69DB53A59E22Q34285956-6ACEFF1D-F04F-450F-A378-CEAB89E9D4D4Q34288485-684830F4-FE52-4C9B-BF7B-8FCA62A48559Q34375289-D41919CA-0AFC-43A9-9E4F-F6F2BD1A8757Q34380222-DE3402FB-EF79-4722-A051-9B7D2682BFB5Q34580424-514F52F1-A640-4088-9C38-58FAC1CCDFF5Q34583994-6042A090-75EB-45BA-91C5-9B41A0E9A155Q34968373-4D656FC7-F71B-4B3C-916A-749B982D7258Q35041508-AA471B9D-525A-4934-BDE8-E3BE6BFC781BQ35061908-286DDED5-50AD-483E-A1C5-B797335FD436Q35485586-4FA6DBA2-8B0A-465A-8472-A449B709DD13Q35574960-34222988-85D3-4B09-9DC7-1BECBA4A2436Q35723517-D261886D-86BD-4EB0-9B68-0EE582E54213Q35754375-EB26FB86-4AE9-4E83-B648-86D8B1F90DBEQ36094168-DE6FEA84-BD8A-46CA-B083-6D6B7C862EA0Q36118754-C08612CC-90B5-4C59-9434-7141F77F74A4Q36157579-8184CBDB-B6EF-4BD4-9FFD-3300CA0F9D55Q36438737-BF74B141-D38A-4E0B-A81A-A07228B6E88FQ36522005-63E07BB4-B629-4CCB-9E5B-B1E704B2573CQ36674248-B69314DB-6A59-4FA0-AA36-D25E843CC300Q36754846-E24F9975-7358-4080-BE20-CBA7AACDDA7D
P2860
Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@ast
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@en
type
label
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@ast
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@en
prefLabel
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@ast
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@en
P1476
Peroxisome proliferator-activa ...... lammation and atherosclerosis.
@en
P2093
P304
P356
10.1097/00041433-199906000-00007
P50
P577
1999-06-01T00:00:00Z